HomeAI · summaries
Storia in 3 fonti
People with atrial fibrillation at intermediate risk of stroke benefit from oral anticoagulants, clinical trial finds
Oral anticoagulant therapy lowered the risk of adverse clinical events compared with no anticoagulation in patients with atrial fibrillation at intermediate stroke risk, according to results from the SINGLE-AF trial presented in a Hot Line session at ESC Congress 2026 and published simultaneously in the New England Journal of Medicine.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
Anticoagulation benefits patients with atrial fibrillation, intermediate stroke risk
MUNICH — In patients with atrial fibrillation and intermediate risk for stroke, direct oral anticoagulants were linked to reduced risk for death, stroke and major bleeding…
- ·
medpagetoday.com
First Major Trial Win for Contemporary DOACs in Lower-Risk Afib
SINGLE-AF trial shows cardiovascular protection without unacceptable bleeding
